# Pharmaceuticals

Latest news and articles about Pharmaceuticals

Total: 16 articles found

Close-up of wooden Scrabble tiles spelling 'UNVERNUFT' against a blurred background.
Business

Cracks in the Citadel: One Year After Trump’s ‘Liberation Day,’ the Cost of Isolationism Mounts

One year after the 'Liberation Day' tariff overhaul, the Trump administration has introduced 100% tariffs on pharmaceuticals and unified 25% levies on metal derivatives. These aggressive moves have accelerated a global shift away from U.S. assets and imposed multi-billion dollar costs on domestic automakers, failing to resolve underlying fiscal deficits.

SoBiz2026年4月3日 09:57
#Trump Administration#Tariffs#Trade War
Modern sale tag offering 50% discount on vibrant red background.
Business

Policy Tailwinds and Tech Optimism Drive China’s Markets to a Strong Second-Quarter Start

China's major stock indices surged over 1% in the first session of the second quarter, led by a 3% jump in the tech-heavy STAR 50. The rally was driven by the pharmaceutical sector and new energy storage policies, even as traditional infrastructure stocks faced a sell-off.

NeMo2026年4月1日 05:58
#A-shares#STAR 50#Pharmaceuticals
Close-up of a medical vial and package with Georgian text on a white background.
Health

China’s Oncology Frontier: Bioken’s Breakthrough Signals New Global Standard in Lung Cancer Treatment

Chinese biotech firm Bioken has reported record-breaking Phase II clinical results for its bispecific ADC lung cancer treatment, achieving a 100% tumor shrinkage rate in target lesions. Backed by a historic $8.4 billion deal with Bristol Myers Squibb, the company’s success highlights China’s rapid ascent from a generic drug producer to a leader in original pharmaceutical innovation.

NeMo2026年3月31日 16:58
#Bioken#Baili-Tianheng#Antibody-Drug Conjugate
Top view stack of books on table near beautiful yellow tulip and orchid flowers arranged with chocolate truffles placed on wicker placemat
Business

A Veteran’s Departure: The Executive Exit Signaling a Crisis in China’s Vaccine Market

The resignation of Wantai Biological’s 20-year veteran board secretary, Yu Tao, underscores a deep crisis in China's vaccine sector. As domestic price wars slash HPV vaccine prices by 90%, the former industry leader is facing massive losses and a desperate pivot toward international markets.

NeMo2026年3月26日 19:58
#Wantai Biological#HPV Vaccine#China Biotech